Literature DB >> 11815455

Sulfonylurea-mediated stimulation of insulin exocytosis via an ATP-sensitive K+ channel-independent action.

Erik Renström1, Sebastian Barg, Frank Thévenod, Patrik Rorsman.   

Abstract

Several reports indicate that hypoglycemic sulfonylureas augment Ca(2+)-dependent insulin secretion via mechanisms other than inhibition of the ATP-sensitive K(+) channel. The effect involves a 65-kd protein in the granule membrane and culminates in intragranular acidification. Lowering of granule pH is necessary for the insulin granule to gain release competence. Proton pumping into the granule is driven by a v-type H(+)-ATPase, but requires simultaneous Cl(-) uptake into the granule via metabolically regulated ClC-3 Cl(-) channels to maintain electroneutrality. Here we discuss the possibility that modulation of granule ClC-3 channels represents the mechanism whereby sulfonylureas directly potentiate the beta-cell exocytotic machinery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11815455     DOI: 10.2337/diabetes.51.2007.s33

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  19 in total

1.  Antidiabetic sulphonylureas activate mitochondrial permeability transition in rat skeletal muscle.

Authors:  Jolanta Skalska; Grazyna Debska; Wolfram S Kunz; Adam Szewczyk
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

Review 2.  Dynamics of insulin secretion and the clinical implications for obesity and diabetes.

Authors:  Susumu Seino; Tadao Shibasaki; Kohtaro Minami
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

3.  High heritability and genetic correlation of intravenous glucose- and tolbutamide-induced insulin secretion among non-diabetic family members of type 2 diabetic patients.

Authors:  Anette P Gjesing; Malene Hornbak; Kristine H Allin; Claus T Ekstrøm; Søren A Urhammer; Hans Eiberg; Oluf Pedersen; Torben Hansen
Journal:  Diabetologia       Date:  2014-03-07       Impact factor: 10.122

4.  Hypoglycaemic effects of glimepiride in sulfonylurea receptor 1 deficient rat.

Authors:  Xiaojun Zhou; Rui Zhang; Zhiwei Zou; Xue Shen; Tianyue Xie; Chunmei Xu; Jianjun Dong; Lin Liao
Journal:  Br J Pharmacol       Date:  2018-12-26       Impact factor: 8.739

Review 5.  Mechanisms of action of glucagon-like peptide 1 in the pancreas.

Authors:  Máire E Doyle; Josephine M Egan
Journal:  Pharmacol Ther       Date:  2006-12-28       Impact factor: 12.310

6.  Tolbutamide potentiates the volume-regulated anion channel current in rat pancreatic beta cells.

Authors:  L Best; S Davies; P D Brown
Journal:  Diabetologia       Date:  2004-11-24       Impact factor: 10.122

Review 7.  Kv1.3: a potential pharmacological target for diabetes.

Authors:  Bok Hee Choi; Sang June Hahn
Journal:  Acta Pharmacol Sin       Date:  2010-08-16       Impact factor: 6.150

8.  Mathematical modeling of insulin secretion and the role of glucose-dependent mobilization, docking, priming and fusion of insulin granules.

Authors:  I Johanna Stamper; Xujing Wang
Journal:  J Theor Biol       Date:  2012-11-12       Impact factor: 2.691

9.  Morphological localisation of sulfonylurea receptor 1 in endocrine cells of human, mouse and rat pancreas.

Authors:  Y Guiot; M Stevens; I Marhfour; P Stiernet; M Mikhailov; S J H Ashcroft; J Rahier; J-C Henquin; C Sempoux
Journal:  Diabetologia       Date:  2007-06-26       Impact factor: 10.122

10.  Acute and long-term effects of nateglinide on insulin secretory pathways.

Authors:  Andrew J Ball; Peter R Flatt; Neville H McClenaghan
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.